home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Partial Duplications Of The MSH2 And MLH1 Genes In Hereditary Nonpolyposis Colorectal Cancer

  January, 25 2007 11:24
your information resource in human molecular genetics
Partial Duplications Of The MSH2 And MLH1 Genes In Hereditary Nonpolyposis Colorectal Cancer

European Journal of Human Genetics

Stephanie Baert-Desurmont, Marie-Pierre Buisine, Emilie Bessenay, Stephanie Frerot, Tonio Lovecchio, Cosette Martin, Sylviane Olschwang, Qing Wang and Thierry Frebourg


Numerous reports have highlighted the contribution of MSH2 and MLH1 genomic deletions to hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch's syndrome, but genomic duplications of these genes have been rarely reported. Using quantitative multiplex PCR of short fluorescent fragments (QMPSF), 962 and 611 index cases were, respectively, screened for MSH2 and MLH1 genomic rearrangements. This allowed us to detect, in 11 families, seven MSH2 duplications affecting exons 1–2–3, exons 4–5–6, exon 7, exons 7–8, exons 9–10, exon 11, and exon 15, and three MLH1 duplications affecting exons 2–3, exon 4 and exons 6–7–8. All duplications were confirmed by an independent method. The contribution of genomic duplications of MSH2 and MLH1 to HNPCC can therefore be estimated approximately to 1% of the HNPCC cases. Although this frequency is much lower than that of genomic deletions, the presence of MSH2 or MLH1 genomic duplications should be considered in HNPCC families without detectable point mutations.

Dr. T. Frebourg, Inserm U614, Faculty of Medicine, 22 Boulevard Gambetta, 76183 Rouen, France.
E-mail: frebourg@chu-rouen.fr

Abstract available online.

(C) European Journal of Human Genetics.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.